Omega Healthcare Investors Earnings Call Transcripts
Fiscal Year 2026
-
Q2 2026 saw strong revenue and net income growth, driven by asset sales and new investments, with leverage at historic lows and a raised AFFO guidance. Portfolio management remains proactive, with no major operator concerns and a robust pipeline in senior housing and U.K. care homes.
-
The meeting saw all board nominees elected, auditor ratified, and executive compensation approved. Management discussed the strategic sale of Communicare assets and addressed dividend policy, noting ongoing board review but no set timeline for increases.
-
Q1 2026 saw strong AFFO and FAD growth, driven by acquisitions and active portfolio management, with a robust investment pipeline and competitive market conditions. Asset sales and redeployment are expected to further boost earnings, while guidance was raised for the year.
Fiscal Year 2025
-
Q4 2025 saw strong revenue and earnings growth, driven by $1.1B in new investments and portfolio management. Guidance for 2026 projects AFFO of $3.15–$3.25 per share, with a robust pipeline and improved operator credit. Balance sheet strength and selective acquisitions position the company for continued growth.
-
Q3 2025 saw strong revenue and earnings growth, with AFFO guidance raised to reflect 8% year-over-year growth. Strategic investments, including a major SABR joint venture, and robust portfolio performance support a positive outlook, while the balance sheet remains strong.
-
Q2 2025 saw strong revenue and earnings growth, driven by acquisitions and portfolio management, with adjusted FFO of $0.77/share and FAD of $0.74/share. Guidance was raised, leverage hit a decade low, and major investments and legislative wins support a positive outlook.
-
Q1 2025 saw strong revenue and earnings growth, driven by new investments and improved operator performance, with leverage at a decade low. Guidance for 2025 AFFO was raised, and the investment pipeline remains robust, especially in the U.S. and U.K.
Fiscal Year 2024
-
Q4 2024 delivered strong revenue and FFO growth, with leverage at a decade low and robust capital deployment, especially in the U.K. 2025 guidance reflects share issuance dilution but anticipates continued AFFO growth, stable operator performance, and a healthy investment pipeline.
-
Q3 results exceeded expectations with FAD at $0.70/share and revenue up 14% year-over-year. AFFO guidance was raised, leverage hit a decade low, and the acquisition pipeline remains robust, with significant investments in senior housing and U.K. care homes.
-
Q2 results exceeded expectations with FAD at $0.68/share and improved leverage. AFFO guidance was raised, supported by robust investment activity, stable rent collections, and a strong balance sheet. Industry fundamentals and occupancy continue to recover.